Precept Management’s Medtronic MDT Stock Holding History

Precept Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,500	Closed	-$624K	–	133
2019 Q4	$624K	Sell	5,500 -5,500	-50%	-$604K	0.3%	57
2019 Q3	$1.2M	Buy	+11,000	New	+$1.15M	0.72%	44

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Precept Management's MDT Position: Q1 2020 in Review

Precept Management sold out of Medtronic (MDT) in Q1 2020, closing a stake of 5,500 shares — an estimated $624K sold.

Precept Management first reported a position in MDT in Q3 2019 and held it in 2 quarters. The position peaked at $1.2M in Q3 2019. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

Precept Management reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
Precept Management sold 5,500 Medtronic shares in Q1 2020, an estimated $624K.
Precept Management first reported a position in Medtronic in Q3 2019 and held it in 2 quarters.
Precept Management's Medtronic position peaked at $1.2M in Q3 2019.
1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Precept Management's 13F filing for Q1 2020, filed 15 May 2020.